Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Szyman Catherine M.. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Szyman Catherine M. har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:NARI / Inari Medical, Inc. | Director | 0 |
US:EW / Edwards Lifesciences Corporation | CVP, Critical Care | 81 287 |
US:OM / Outset Medical, Inc. | Director | 24 596 |
SrVP & Pres Diabetes | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Szyman Catherine M.. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp OM / Outset Medical, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i OM / Outset Medical, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i OM / Outset Medical, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Szyman Catherine M. som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-02-19 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
U - Other | −22 429 | 0 | −100,00 | ||||
2024-09-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −5 530 | 81 287 | −6,37 | 69,96 | −386 879 | 5 686 869 | |
2024-09-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 10 910 | 86 817 | 14,37 | ||||
2024-07-08 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −258 | 75 907 | −0,34 | 92,32 | −23 819 | 7 007 775 | |
2024-05-31 |
|
4/A | NARI |
Inari Medical, Inc.
Common Stock |
A - Award | 4 126 | 22 429 | 22,54 | 42,41 | 174 984 | 951 214 | |
2024-05-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −827 | 76 165 | −1,07 | 86,72 | −71 717 | 6 605 067 | |
2024-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −609 | 76 992 | −0,78 | 85,09 | −51 820 | 6 551 286 | |
2024-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 32 025 | 77 601 | 70,27 | ||||
2024-05-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −3 442 | 45 576 | −7,02 | 85,25 | −293 430 | 3 885 391 | |
2024-05-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 5 796 | 49 018 | 13,41 | ||||
2024-05-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −479 | 43 222 | −1,10 | 85,06 | −40 744 | 3 676 501 | |
2024-04-26 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
A - Award | 4 126 | 22 429 | 22,54 | 42,41 | 174 984 | 951 214 | |
2024-02-23 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 8 560 | 43 374 | 24,59 | ||||
2024-02-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | −27 000 | 34 814 | −43,68 | 85,62 | −2 311 654 | 2 980 627 | |
2024-02-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 27 000 | 61 814 | 77,56 | 36,75 | 992 250 | 2 271 649 | |
2024-02-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | −20 000 | 34 814 | −36,49 | 86,46 | −1 729 200 | 3 009 981 | |
2024-02-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 20 000 | 54 814 | 57,45 | 36,75 | 735 000 | 2 014 399 | |
2023-10-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −5 000 | 34 814 | −12,56 | 72,68 | −363 400 | 2 530 250 |
2023-10-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 5 000 | 39 814 | 14,36 | 36,75 | 183 750 | 1 463 149 |
2023-09-08 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −5 000 | 34 814 | −12,56 | 76,00 | −380 000 | 2 645 831 |
2023-09-08 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 5 000 | 39 814 | 14,36 | 36,75 | 183 750 | 1 463 149 |
2023-08-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −5 000 | 34 814 | −12,56 | 78,64 | −393 185 | 2 737 635 |
2023-08-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 5 000 | 39 814 | 14,36 | 36,75 | 183 750 | 1 463 149 |
2023-07-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −5 000 | 34 814 | −12,56 | 90,52 | −452 600 | 3 151 324 |
2023-07-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 5 000 | 39 814 | 14,36 | 36,75 | 183 750 | 1 463 149 |
2023-07-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −252 | 34 814 | −0,72 | 90,46 | −22 796 | 3 149 236 | |
2023-06-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −5 000 | 35 056 | −12,48 | 85,81 | −429 045 | 3 008 101 |
2023-06-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 5 000 | 40 056 | 14,26 | 36,75 | 183 750 | 1 472 050 |
2023-05-31 |
|
4 | OM |
Outset Medical, Inc.
Common Stock |
A - Award | 7 681 | 24 596 | 45,41 | ||||
2023-05-19 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
A - Award | 2 412 | 18 303 | 15,18 | ||||
2023-05-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 6 525 | 35 056 | 22,87 | ||||
2023-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −75 600 | 28 531 | −72,60 | 88,94 | −6 724 234 | 2 537 667 |
2023-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 75 600 | 104 131 | 264,98 | 35,20 | 2 660 871 | 3 665 060 |
2023-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 376 | 28 531 | −4,60 | 88,74 | −122 106 | 2 531 821 | |
2023-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −2 154 | 29 907 | −6,72 | 88,74 | −191 146 | 2 653 928 | |
2023-05-09 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 4 708 | 32 061 | 17,21 | ||||
2023-05-04 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −344 | 27 353 | −1,24 | 88,10 | −30 306 | 2 409 780 | |
2023-05-04 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −327 | 27 697 | −1,17 | 87,81 | −28 714 | 2 432 054 | |
2023-02-13 |
|
5 | EW |
Edwards Lifesciences Corp
Common Stock |
G - Gift | −7 676 | 27 698 | −21,70 | ||||
2022-12-14 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
G - Gift | −16 000 | 15 891 | −50,17 | ||||
2022-07-07 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 2 032 | 35 374 | 6,09 | ||||
2022-06-01 |
|
4 | OM |
Outset Medical, Inc.
Common Stock |
A - Award | 6 880 | 16 915 | 68,56 | ||||
2022-05-27 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
A - Award | 2 420 | 31 891 | 8,21 | ||||
2022-05-17 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 730 | 33 304 | −4,94 | 95,93 | −165 959 | 3 194 820 | |
2022-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
M - Exercise | −12 206 | 0 | −100,00 | ||||
2022-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −7 428 | 35 034 | −17,49 | 100,52 | −746 663 | 3 521 583 | |
2022-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 12 206 | 42 462 | 40,34 | ||||
2022-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −595 | 30 256 | −1,93 | 100,52 | −59 809 | 3 041 299 | |
2022-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −23 400 | 0 | −100,00 | ||||
2022-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −10 449 | 30 851 | −25,30 | 105,10 | −1 098 173 | 3 242 355 |
2022-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −9 155 | 41 300 | −18,15 | 104,18 | −953 739 | 4 302 466 |
2022-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −3 796 | 50 455 | −7,00 | 105,88 | −401 916 | 5 342 079 |
2022-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −493 | 54 251 | −0,90 | 105,93 | −52 223 | 5 746 772 | |
2022-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 23 400 | 54 744 | 74,66 | 21,76 | 509 184 | 1 191 222 |
2022-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 4 725 | 4 725 | |||||
2022-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 30 600 | 30 600 | |||||
2022-05-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 3 775 | 31 344 | 13,69 | ||||
2022-04-11 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −20 000 | 23 400 | −46,08 | ||||
2022-04-11 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −9 821 | 27 569 | −26,27 | 121,37 | −1 191 963 | 3 345 975 |
2022-04-11 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 579 | 37 390 | −14,96 | 123,00 | −809 222 | 4 598 954 |
2022-04-11 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −3 600 | 43 969 | −7,57 | 122,12 | −439 629 | 5 369 417 |
2022-04-11 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 20 000 | 47 569 | 72,55 | 21,76 | 435 200 | 1 035 094 |
2022-03-14 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −20 000 | 43 400 | −31,55 | ||||
2022-03-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −11 853 | 27 415 | −30,19 | 104,88 | −1 243 178 | 2 875 317 |
2022-03-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −8 147 | 39 268 | −17,18 | 104,31 | −849 823 | 4 096 038 |
2022-03-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 20 000 | 47 415 | 72,95 | 21,76 | 435 200 | 1 031 740 |
2022-02-18 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −20 000 | 63 400 | −23,98 | ||||
2022-02-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −13 100 | 27 415 | −32,33 | 106,62 | −1 396 674 | 2 922 835 |
2022-02-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 900 | 40 515 | −14,55 | 105,74 | −729 579 | 4 283 848 |
2022-02-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 20 000 | 47 415 | 72,95 | 21,76 | 435 200 | 1 031 740 |
2022-01-14 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −10 000 | 83 400 | −10,71 | ||||
2022-01-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −8 884 | 27 415 | −24,47 | 119,47 | −1 061 329 | 3 275 081 |
2022-01-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −1 116 | 36 299 | −2,98 | 120,01 | −133 934 | 4 356 291 |
2022-01-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 10 000 | 37 415 | 36,48 | 21,76 | 217 600 | 814 140 |
2021-12-17 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −10 000 | 93 400 | −9,67 | ||||
2021-12-17 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −10 000 | 27 415 | −26,73 | 121,24 | −1 212 400 | 3 323 737 |
2021-12-17 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 10 000 | 37 415 | 36,48 | 21,76 | 217 600 | 814 140 |
2021-11-19 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −10 000 | 103 400 | −8,82 | ||||
2021-11-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −6 357 | 27 415 | −18,82 | 117,88 | −749 394 | 3 231 758 |
2021-11-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 390 | 33 772 | −6,61 | 116,98 | −279 586 | 3 950 650 |
2021-11-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −1 253 | 36 162 | −3,35 | 118,87 | −148 947 | 4 298 607 |
2021-11-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 10 000 | 37 415 | 36,48 | 21,76 | 217 600 | 814 140 |
2021-10-18 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −9 741 | 113 400 | −7,91 | ||||
2021-10-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −7 138 | 27 415 | −20,66 | 110,24 | −786 883 | 3 022 139 |
2021-10-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 603 | 34 553 | −7,01 | 110,87 | −288 599 | 3 830 890 |
2021-10-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 9 741 | 37 156 | 35,53 | 21,76 | 211 964 | 808 504 |
2021-09-08 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −9 741 | 123 141 | −7,33 | ||||
2021-09-08 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −9 741 | 27 415 | −26,22 | 121,28 | −1 181 362 | 3 324 759 |
2021-09-08 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 9 741 | 37 156 | 35,53 | 21,76 | 211 964 | 808 504 |
2021-08-05 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
G - Gift | −344 | 27 415 | −1,24 | ||||
2021-08-02 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −15 000 | 132 882 | −10,14 | ||||
2021-08-02 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | −15 000 | 27 759 | −35,08 | 113,53 | −1 702 904 | 3 151 383 | |
2021-08-02 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 15 000 | 42 759 | 54,04 | 21,76 | 326 400 | 930 434 | |
2021-06-15 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −3 410 | 0 | −100,00 | ||||
2021-06-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −3 410 | 27 705 | −10,96 | 101,17 | −344 990 | 2 802 894 |
2021-06-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 3 410 | 31 115 | 12,31 | 22,29 | 75 998 | 693 446 |
2021-06-04 |
|
4 | OM |
Outset Medical, Inc.
Common Stock |
A - Award | 3 288 | 10 035 | 48,73 | ||||
2021-05-28 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
A - Award | 1 380 | 29 471 | 4,91 | ||||
2021-05-28 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 061 | 27 705 | −6,92 | 95,29 | −196 393 | 2 639 990 |
2021-05-25 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −4 665 | 29 766 | −13,55 | 96,09 | −448 300 | 2 860 195 |
2021-05-24 |
|
4 | OM |
Outset Medical, Inc.
Common Stock |
A - Award | 5 747 | 6 747 | 574,70 | ||||
2021-05-24 | 3 | OM |
Outset Medical, Inc.
Common Stock |
1 000 | ||||||||
2021-05-19 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
M - Exercise | −15 225 | 0 | −100,00 | ||||
2021-05-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −7 549 | 34 431 | −17,98 | 89,49 | −675 560 | 3 081 249 | |
2021-05-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 729 | 41 980 | −3,96 | 89,49 | −154 728 | 3 756 809 | |
2021-05-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 15 225 | 43 709 | 53,45 | ||||
2021-05-12 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −2 028 | 28 484 | −6,65 | 90,40 | −183 331 | 2 574 973 | |
2021-05-11 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −428 | 33 901 | −1,25 | 91,75 | −39 269 | 3 110 436 | |
2021-05-07 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −3 389 | 3 410 | −49,85 | ||||
2021-05-07 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −3 389 | 30 940 | −9,87 | 91,87 | −311 347 | 2 842 478 |
2021-05-07 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 3 389 | 34 329 | 10,95 | 22,29 | 75 530 | 765 085 |
2021-05-06 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 4 950 | 4 950 | |||||
2021-05-06 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 34 600 | 34 600 | |||||
2021-05-06 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 3 975 | 30 940 | 14,74 | ||||
2021-04-22 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −3 389 | 6 799 | −33,26 | ||||
2021-04-22 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −3 389 | 26 966 | −11,16 | 94,40 | −319 922 | 2 545 596 |
2021-04-22 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 3 389 | 30 355 | 12,57 | 22,29 | 75 530 | 676 514 |
2021-03-15 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −3 389 | 10 188 | −24,96 | ||||
2021-03-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −3 389 | 26 746 | −11,25 | 81,66 | −276 746 | 2 184 090 |
2021-03-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 3 389 | 30 135 | 12,67 | 22,29 | 75 530 | 671 613 |
2021-02-16 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −3 389 | 13 577 | −19,98 | ||||
2021-02-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −3 389 | 26 746 | −11,25 | 88,20 | −298 910 | 2 359 010 |
2021-02-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 3 389 | 30 135 | 12,67 | 22,29 | 75 530 | 671 613 |
2021-01-15 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −3 389 | 16 966 | −16,65 | ||||
2021-01-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −3 389 | 26 746 | −11,25 | 87,27 | −295 758 | 2 334 136 |
2021-01-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 3 389 | 30 135 | 12,67 | 22,29 | 75 530 | 671 613 |
2020-10-29 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | −20 355 | 20 355 | −50,00 | ||||
2020-10-29 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | −20 355 | 26 746 | −43,22 | 73,24 | −1 490 884 | 1 958 997 | |
2020-10-29 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 20 355 | 47 101 | 76,10 | 22,29 | 453 646 | 1 049 729 | |
2020-08-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 249 | 26 746 | −7,76 | 78,24 | −175 962 | 2 092 618 |
2020-07-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 249 | 28 995 | −7,20 | 67,66 | −152 167 | 1 961 811 |
2020-06-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −3 348 | 31 216 | −9,69 | 70,67 | −236 603 | 2 206 011 |
2020-06-11 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 249 | 34 564 | −6,11 | 72,59 | −163 255 | 2 508 977 |
2020-05-27 |
|
4 | NARI |
Inari Medical, Inc.
Common Stock |
P - Purchase | 28 091 | 28 091 | 19,00 | 533 729 | 533 729 | ||
2020-05-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −1 116 | 12 271 | −8,34 | 212,69 | −237 362 | 2 609 896 |
2020-05-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −750 | 13 387 | −5,31 | 216,93 | −162 698 | 2 904 018 |
2020-05-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −682 | 14 137 | −4,60 | 225,05 | −153 484 | 3 181 507 | |
2020-05-13 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
M - Exercise | −5 950 | 0 | −100,00 | ||||
2020-05-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −2 951 | 14 819 | −16,61 | 217,84 | −642 846 | 3 228 147 | |
2020-05-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −548 | 17 770 | −2,99 | 217,84 | −119 376 | 3 870 993 | |
2020-05-13 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 5 950 | 18 318 | 48,11 | ||||
2020-05-08 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 2 000 | 2 000 | |||||
2020-05-08 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 14 600 | 14 600 | |||||
2020-05-08 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 1 600 | 12 368 | 14,86 | ||||
2020-04-30 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
G - Gift | X | −3 987 | 10 768 | −27,02 | |||
2020-04-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −1 116 | 14 755 | −7,03 | 216,91 | −242 072 | 3 200 483 |
2020-03-23 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −1 116 | 15 773 | −6,61 | 162,95 | −181 852 | 2 570 246 |
2020-02-18 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −2 500 | 13 570 | −15,56 | |||
2020-02-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 500 | 16 889 | −12,89 | 228,57 | −571 425 | 3 860 368 |
2020-02-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 2 500 | 19 389 | 14,80 | 66,86 | 167 150 | 1 296 363 |
2020-02-03 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −2 500 | 16 070 | −13,46 | |||
2020-02-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 500 | 16 889 | −12,89 | 219,50 | −548 750 | 3 707 183 |
2020-02-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 2 500 | 19 389 | 14,80 | 66,86 | 167 150 | 1 296 363 |
2020-01-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
G - Gift | X | −222 | 16 889 | −1,30 | |||
2019-12-16 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −2 500 | 18 570 | −11,87 | |||
2019-12-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 500 | 17 105 | −12,75 | 234,27 | −585 686 | 4 007 223 |
2019-12-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 2 500 | 19 605 | 14,62 | 66,86 | 167 150 | 1 310 778 |
2019-11-15 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −2 500 | 21 070 | −10,61 | |||
2019-11-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 500 | 17 105 | −12,75 | 242,14 | −605 350 | 4 141 760 |
2019-11-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 2 500 | 19 605 | 14,62 | 66,86 | 167 150 | 1 310 778 |
2019-10-25 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −2 500 | 23 570 | −9,59 | 66,86 | −167 150 | 1 575 890 |
2019-10-25 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 500 | 17 105 | −12,75 | 227,19 | −567 975 | 3 886 043 |
2019-10-25 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 2 500 | 19 605 | 14,62 | 66,86 | 167 150 | 1 310 778 |
2019-09-20 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
M - Exercise | X | −2 500 | 26 070 | −8,75 | |||
2019-09-20 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
G - Gift | −583 | 17 055 | −3,31 | ||||
2019-09-20 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −2 500 | 17 638 | −12,41 | 216,71 | −541 775 | 3 822 340 |
2019-09-20 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | X | 2 500 | 20 138 | 14,17 | 66,86 | 167 150 | 1 346 429 |
2019-08-30 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −334 | 0 | −100,00 | 222,00 | −74 148 | |
2019-08-30 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −372 | 17 638 | −2,07 | 222,00 | −82 584 | 3 915 645 |
2019-08-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −328 | 334 | −49,55 | 214,53 | −70 366 | 71 653 |
2019-08-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −372 | 18 010 | −2,02 | 214,53 | −79 805 | 3 863 694 |
2019-07-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −328 | 662 | −33,13 | 191,70 | −62 878 | 126 905 |
2019-07-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −780 | 18 382 | −4,07 | 191,70 | −149 526 | 3 523 837 |
2019-07-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −372 | 19 162 | −1,90 | 191,70 | −71 312 | 3 673 363 |
2019-06-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −328 | 990 | −24,89 | 184,55 | −60 532 | 182 704 |
2019-06-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −774 | 19 476 | −3,82 | 184,55 | −142 842 | 3 594 217 |
2019-06-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −372 | 20 250 | −1,80 | 184,55 | −68 653 | 3 737 059 |
2019-05-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −328 | 1 318 | −19,93 | 177,92 | −58 358 | 234 499 |
2019-05-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −774 | 20 622 | −3,62 | 177,92 | −137 710 | 3 668 990 |
2019-05-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −372 | 21 396 | −1,71 | 177,92 | −66 186 | 3 806 700 |
2019-05-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 066 | 21 768 | −4,67 | 178,17 | −189 929 | 3 878 328 | |
2019-05-14 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
M - Exercise | −2 595 | 0 | −100,00 | ||||
2019-05-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 287 | 22 834 | −5,34 | 181,10 | −233 076 | 4 135 160 | |
2019-05-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −682 | 24 121 | −2,75 | 181,10 | −123 510 | 4 368 236 | |
2019-05-14 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 2 595 | 24 803 | 11,69 | ||||
2019-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 2 325 | 2 325 | |||||
2019-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 16 400 | 16 400 | |||||
2019-05-10 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 1 850 | 22 208 | 9,09 | ||||
2019-04-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −328 | 1 646 | −16,62 | 192,00 | −62 976 | 316 032 |
2019-04-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −774 | 20 358 | −3,66 | 192,00 | −148 608 | 3 908 654 |
2019-04-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −372 | 21 132 | −1,73 | 192,00 | −71 424 | 4 057 262 |
2019-03-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −328 | 1 974 | −14,25 | 179,10 | −58 745 | 353 543 |
2019-03-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −774 | 21 455 | −3,48 | 179,10 | −138 623 | 3 842 618 |
2019-03-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −372 | 22 229 | −1,65 | 179,10 | −66 625 | 3 981 241 |
2019-02-21 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −328 | 2 302 | −12,47 | 176,34 | −57 840 | 405 935 |
2019-02-21 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −774 | 22 601 | −3,31 | 176,34 | −136 487 | 3 985 487 |
2019-02-21 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −372 | 23 375 | −1,57 | 176,34 | −65 598 | 4 121 974 |
2019-02-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −2 227 | 23 747 | −8,57 | 177,78 | −395 916 | 4 221 769 | |
2019-02-19 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −697 | 25 974 | −2,61 | 177,78 | −123 913 | 4 617 685 | |
2019-01-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −328 | 2 630 | −11,09 | 155,00 | −50 840 | 407 650 |
2019-01-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −372 | 26 671 | −1,38 | 155,00 | −57 660 | 4 134 029 |
2018-12-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −328 | 2 958 | −9,98 | 162,66 | −53 352 | 481 148 |
2018-12-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −372 | 27 028 | −1,36 | 162,66 | −60 510 | 4 396 343 |
2018-11-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −328 | 3 286 | −9,08 | 147,96 | −48 531 | 486 197 |
2018-11-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −372 | 27 400 | −1,34 | 147,96 | −55 041 | 4 054 075 |
2018-10-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −328 | 3 614 | −8,32 | 142,64 | −46 786 | 515 501 |
2018-10-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −372 | 27 772 | −1,32 | 142,64 | −53 062 | 3 961 370 |
2018-05-24 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | −9 815 | 28 001 | −25,95 | 139,39 | −1 368 113 | 3 903 092 | |
2018-05-21 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 2 900 | 2 900 | |||||
2018-05-21 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 20 000 | 20 000 | |||||
2018-05-21 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 2 325 | 37 816 | 6,55 | ||||
2018-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
M - Exercise | −9 362 | 0 | −100,00 | ||||
2018-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −4 642 | 35 491 | −11,57 | 136,43 | −633 308 | 4 842 069 | |
2018-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
M - Exercise | 9 362 | 40 133 | 30,42 | ||||
2018-05-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −1 066 | 30 771 | −3,35 | 138,11 | −147 225 | 4 249 815 | |
2018-02-22 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −2 159 | 31 773 | −6,36 | 133,82 | −288 917 | 4 251 909 | |
2018-02-22 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −500 | 33 932 | −1,45 | 133,82 | −66 910 | 4 540 826 | |
2017-08-01 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −4 681 | 34 330 | −12,00 | 115,78 | −541 966 | 3 974 704 |
2017-07-03 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
S - Sale | X | −4 716 | 38 921 | −10,81 | 118,11 | −557 007 | 4 596 976 |
2017-05-26 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −2 364 | 43 637 | −5,14 | 89,74 | −212 145 | 3 915 997 | |
2017-05-26 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −527 | 46 001 | −1,13 | 89,74 | −47 293 | 4 128 143 | |
2017-05-15 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 3 400 | 3 400 | |||||
2017-05-15 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 24 000 | 24 000 | |||||
2017-05-15 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 2 725 | 46 528 | 6,22 | ||||
2016-12-02 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
P - Purchase | 3 942 | 3 942 | 83,33 | 328 487 | 328 487 | ||
2016-12-02 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
P - Purchase | 8 928 | 43 690 | 25,68 | 83,47 | 745 206 | 3 646 711 | |
2016-05-16 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 3 425 | 3 425 | |||||
2016-05-16 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 25 200 | 25 200 | |||||
2016-05-16 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 2 750 | 34 570 | 8,64 | ||||
2016-02-22 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −2 319 | 31 734 | −6,81 | 86,24 | −199 991 | 2 736 740 | |
2016-02-22 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
F - Taxes | −537 | 34 053 | −1,55 | 86,24 | −46 311 | 2 936 731 | |
2015-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Performance Rights |
A - Award | 2 675 | 2 675 | |||||
2015-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 3 247 | 24 647 | 15,17 | ||||
2015-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 21 400 | 21 400 | |||||
2015-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 2 150 | 17 295 | 14,20 | ||||
2015-05-18 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 2 805 | 15 145 | 22,73 | ||||
2015-02-23 |
|
4 | EW |
Edwards Lifesciences Corp
Employee Stock Option (Right to Acquire) |
A - Award | 14 285 | 14 285 | |||||
2015-02-23 |
|
4 | EW |
Edwards Lifesciences Corp
Common Stock |
A - Award | 12 340 | 12 340 | |||||
2014-04-21 |
|
4 | MDT |
MEDTRONIC INC
Employee Stock Option (right to buy) |
M - Exercise | −13 219 | 0 | −100,00 | ||||
2014-04-21 |
|
4 | MDT |
MEDTRONIC INC
Employee Stock Option (right to buy) |
M - Exercise | −9 241 | 0 | −100,00 | ||||
2014-04-21 |
|
4 | MDT |
MEDTRONIC INC
Employee Stock Option (right to buy) |
M - Exercise | −6 960 | 0 | −100,00 | ||||
2014-04-21 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
S - Sale | X | −29 420 | 21 602 | −57,66 | 58,79 | −1 729 519 | 1 269 939 |
2014-04-21 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
M - Exercise | 13 219 | 51 022 | 34,97 | 56,74 | 750 046 | 2 895 005 | |
2014-04-21 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
M - Exercise | 9 241 | 37 803 | 32,35 | 48,70 | 450 037 | 1 841 021 | |
2014-04-21 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
M - Exercise | 6 960 | 28 562 | 32,22 | 35,92 | 250 003 | 1 025 958 | |
2014-03-21 |
|
4 | MDT |
MEDTRONIC INC
Employee Stock Option (right to buy) |
M - Exercise | −644 | 25 123 | −2,50 | ||||
2014-03-21 |
|
4 | MDT |
MEDTRONIC INC
Employee Stock Option (right to buy) |
M - Exercise | −14 335 | 14 335 | −50,00 | ||||
2014-03-21 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
S - Sale | X | −14 979 | 21 542 | −41,01 | 59,57 | −892 338 | 1 283 331 |
2014-03-21 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
M - Exercise | 644 | 36 521 | 1,80 | 38,81 | 24 994 | 1 417 392 | |
2014-03-21 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
M - Exercise | 14 335 | 35 877 | 66,54 | 34,88 | 500 005 | 1 251 400 | |
2013-08-28 |
|
4 | MDT |
MEDTRONIC INC
Employee Stock Option (right to buy) |
M - Exercise | −18 985 | 6 329 | −75,00 | ||||
2013-08-28 |
|
4 | MDT |
MEDTRONIC INC
Employee Stock Option (right to buy) |
M - Exercise | −6 899 | 0 | −100,00 | ||||
2013-08-28 |
|
4 | MDT |
MEDTRONIC INC
Employee Stock Option (right to buy) |
M - Exercise | −15 000 | 0 | −100,00 | ||||
2013-08-28 |
|
4 | MDT |
MEDTRONIC INC
Employee Stock Option (right to buy) |
M - Exercise | −2 973 | 0 | −100,00 | ||||
2013-08-28 |
|
4 | MDT |
MEDTRONIC INC
Employee Stock Option (right to buy) |
M - Exercise | −9 561 | 0 | −100,00 | ||||
2013-08-28 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
S - Sale | −56 998 | 21 217 | −72,87 | 52,60 | −2 998 334 | 1 116 100 | |
2013-08-28 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
M - Exercise | 18 985 | 78 215 | 32,05 | 37,53 | 712 507 | 2 935 407 | |
2013-08-28 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
M - Exercise | 6 899 | 59 230 | 13,18 | 36,24 | 250 020 | 2 146 493 | |
2013-08-28 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
M - Exercise | 15 000 | 52 331 | 40,18 | 50,00 | 750 000 | 2 616 547 | |
2013-08-28 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
M - Exercise | 2 973 | 37 331 | 8,65 | 50,46 | 150 018 | 1 883 719 | |
2013-08-28 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
M - Exercise | 9 561 | 34 358 | 38,56 | 46,01 | 439 902 | 1 580 809 | |
2013-08-06 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
F - Taxes | −2 157 | 24 797 | −8,00 | 54,94 | −118 506 | 1 362 344 | |
2013-07-31 |
|
4 | MDT |
MEDTRONIC INC
Employee Stock Option (right to buy) |
A - Award | 24 096 | 25 904 | 1 332,74 | ||||
2013-07-31 |
|
4 | MDT |
MEDTRONIC INC
Employee Stock Option (right to buy) |
A - Award | 1 808 | 1 808 | |||||
2013-07-31 |
|
4 | MDT |
MEDTRONIC INC
Common Stock |
A - Award | 6 020 | 26 954 | 28,76 | ||||
2012-11-16 | 3 | MDT |
MEDTRONIC INC
Common Stock |
20 244 |